Works matching Integrase inhibitors


Results: 2045
    1
    2

    Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study.

    Published in:
    HIV Medicine, 2025, v. 26, n. 1, p. 166, doi. 10.1111/hiv.13698
    By:
    • Ursenbach, Axel;
    • Sireyjol, Antoine;
    • Delpierre, Cyrille;
    • Duvivier, Claudine;
    • Hocqueloux, Laurent;
    • Rey, David;
    • Chirouze, C.;
    • Bouiller, K.;
    • Bozon, F.;
    • Brunel, AS.;
    • Hustache‐Mathieu, L.;
    • Lagoutte, J.;
    • Lepiller, Q.;
    • Marty‐Quinternet, S.;
    • Pépin‐Puget, L.;
    • Rosolen, B.;
    • Tissot, N.;
    • Jaffuel, S.;
    • Ansart, S;
    • Quintric, Y
    Publication type:
    Article
    3
    4
    5
    6
    7

    HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana †.

    Published in:
    Viruses (1999-4915), 2021, v. 13, n. 4, p. 594, doi. 10.3390/v13040594
    By:
    • Seatla, Kaelo K.;
    • Maruapula, Dorcas;
    • Choga, Wonderful T.;
    • Ntsipe, Tshenolo;
    • Mathiba, Nametso;
    • Mogwele, Mompati;
    • Kapanda, Max;
    • Nkomo, Bornapate;
    • Ramaabya, Dinah;
    • Makhema, Joseph;
    • Mmalane, Mompati;
    • Mine, Madisa;
    • Kasvosve, Ishmael;
    • Lockman, Shahin;
    • Moyo, Sikhulile;
    • Gaseitsiwe, Simani;
    • Grevenynghe, Julien Van
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.

    Published in:
    2020
    By:
    • Tzou, Philip L;
    • Rhee, Soo-Yon;
    • Descamps, Diane;
    • Clutter, Dana S;
    • Hare, Bradley;
    • Mor, Orna;
    • Grude, Maxime;
    • Parkin, Neil;
    • Jordan, Michael R;
    • Bertagnolio, Silvia;
    • Schapiro, Jonathan M;
    • Harrigan, P Richard;
    • Geretti, Anna Maria;
    • Marcelin, Anne-Geneviève;
    • Shafer, Robert W;
    • Groups, on behalf of the WHO HIVResNet Working;
    • WHO HIVResNet Working Groups
    Publication type:
    journal article
    19
    20
    21

    Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination With Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection Among People With HIV.

    Published in:
    Clinical Infectious Diseases, 2024, v. 78, n. 5, p. 1295, doi. 10.1093/cid/ciad730
    By:
    • Lin, Kuan-Yin;
    • Sun, Hsin-Yun;
    • Yang, Chia-Jui;
    • Lu, Po-Liang;
    • Lee, Yuan-Ti;
    • Lee, Nan-Yao;
    • Liou, Bo-Huang;
    • Tang, Hung-Jen;
    • Lee, Mei-Hui;
    • Wang, Ning-Chi;
    • Chen, Tun-Chieh;
    • Hii, Ing-Moi;
    • Huang, Sung-Hsi;
    • Lin, Chi-Ying;
    • Tsai, Chin-Shiang;
    • Cheng, Chien-Yu;
    • Hung, Chien-Ching;
    • Group, the Taiwan HIV Study
    Publication type:
    Article
    22
    23
    24

    Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada.

    Published in:
    Journal of the International AIDS Society, 2020, v. 23, n. 4, p. 1, doi. 10.1002/jia2.25484
    By:
    • Bourgi, Kassem;
    • Jenkins, Cathy A;
    • Rebeiro, Peter F;
    • Palella, Frank;
    • Moore, Richard D;
    • Altoff, Keri N;
    • Gill, John;
    • Rabkin, Charles S;
    • Gange, Stephen J;
    • Horberg, Michael A;
    • Margolick, Joseph;
    • Li, Jun;
    • Wong, Cherise;
    • Willig, Amanda;
    • Lima, Viviane D;
    • Crane, Heidi;
    • Thorne, Jennifer;
    • Silverberg, Michael;
    • Kirk, Gregory;
    • Mathews, William C
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32

    Comparison of treatment‐emergent resistance‐associated mutations and discontinuation due to adverse events among integrase strand transfer inhibitor‐based single‐tablet regimens and cabotegravir + rilpivirine for the treatment of virologically suppressed people with HIV: A systematic literature review and network meta‐analysis

    Published in:
    HIV Medicine, 2025, v. 26, n. 8, p. 1184, doi. 10.1111/hiv.70050
    By:
    • Rashid, Ishfaq;
    • Unger, Nathan R.;
    • Willis, Connor;
    • Dhippayom, Teerapon;
    • Ramgopal, Moti;
    • Sherman, Elizabeth M.;
    • Yared, Nicholas;
    • Safran, Rachel;
    • Swiatlo, Edwin;
    • Weinberg, Amy R.;
    • Navadeh, Soodi;
    • Schmutz, Howard Weston;
    • Chaiyakunapruk, Nathorn
    Publication type:
    Article
    33
    34
    35

    Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV.

    Published in:
    AIDS & Behavior, 2021, v. 25, n. 1, p. 225, doi. 10.1007/s10461-020-02967-2
    By:
    • Kamkwalala, Asante R.;
    • Wang, Kunbo;
    • O'Halloran, Jane;
    • Williams, Dionna W.;
    • Dastgheyb, Raha;
    • Fitzgerald, Kathryn C.;
    • Spence, Amanda B.;
    • Maki, Pauline M.;
    • Gustafson, Deborah R.;
    • Milam, Joel;
    • Sharma, Anjali;
    • Weber, Kathleen M.;
    • Adimora, Adaora A.;
    • Ofotokun, Igho;
    • Sheth, Anandi N.;
    • Lahiri, Cecile D.;
    • Fischl, Margaret A.;
    • Konkle-Parker, Deborah;
    • Xu, Yanxun;
    • Rubin, Leah H.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50